September 27, 2013

Sanofi and Aviesan Renew their Agreement to Accelerate Research in France

Three-year renewal of the cooperation protocol

 

Sanofi and Aviesan Renew their Agreement to Accelerate Research in France
Three-year renewal of the cooperation protocol

Paris, France – September 27, 2013 – Sanofi (EURONEXT: SAN and NYSE: SNY) and Aviesan1, the French National Alliance for Life Sciences and Health today announced that they have renewed for a period of three years the cooperation protocol signed in 2010.The aim is to contribute to the development of new treatments that target unmet medical needs, including those in the field of rare diseases, to participate to the excellence and consolidation of research in French industry on an international level. Special emphasis will be put on translational research projects that bring together clinical and medical teams with fundamental research teams to translate research successes into medical advances.